✦ LIBER ✦

Partial hepatic resection under intermittent hepatic inflow occlusion in patients with chronic liver disease

✍ Scribed by Dr T. Ezaki; Y. Seo; H. Tomoda; M. Furusawa; T. Kanematsu; K. Sugimachi

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 241 KB
Volume: 79
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800790311

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A partial hepatic resection was performed in 13 patients with chronic liver disease using intermittent hepatic inflow occlusion. Eleven patients had liver cirrhosis and two had chronic hepatitis. Seven patients were classified as Child's grade A and six as Child's grade B before operation. Dissection of the hepatic parenchyma was performed during intermittent inflow occlusion. The time of clamping and declamping was 10–20 min and 5–8 min, respectively. Postoperative data on liver function showed recovery to preoperative levels by about 10 days after operation. There were no life-threatening complications. These results indicate that intermittent hepatic inflow occlusion can be achieved easily and safely to allow non-anatomical resection in patients with chronic liver disease.

📜 SIMILAR VOLUMES

Safety and immunogenicity of hepatitis A

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec

Outcome of hypovascular hepatic nodules

Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease

✍ Utaroh Motosugi; Tomoaki Ichikawa; Katsuhiro Sano; Hironobu Sou; Kojiro Onohara; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

## Abstract ## Purpose: To elucidate the natural history of hypovascular nodules that appear hypointense on hepatocyte‐phase gadoxetic acid‐enhanced MR images by focusing on hypervascularization over time. ## Materials and Methods: In this study, 135 hypovascular nodules revealing no gadoxetic a

End-stage liver disease and liver transp

End-stage liver disease and liver transplantation: Role of lamivudine therapy in patients with chronic hepatitis B

✍ Emmet B. Keeffe 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

Serologically silent hepatitis B virus c

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: Clinical and virological significance

✍ Fukuda, Ryo; Ishimura, Norihisa; Niigaki, Misa; Hamamoto, Sachiko; Satoh, Shuich 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 2 views

Frequent coinfection of surface antigen-negative hepatitis B virus (silent HBV) in hepatitis C virus (HCV)-associated chronic liver disease (CLD) has been reported. The clinical and virological significance of silent HBV infection was investigated in 65 patients with HCV-associated CLD who subsequen

Susceptibility to hepatitis A in patient

Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: Missed opportunities for vaccination

✍ Michael Shim; Inessa Khaykis; James Park; Edmund J. Bini 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with underlying chronic liver disease. Although HAV vaccination is recommended for all patients with chronic hepatitis C virus (HCV) infection, little is known about adherence to these recomm